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Abstract
Vascular endothelial growth factor A (VEGFA) isoform treatment has been demonstrated to alter
spermatogonial stem cell homeostasis. Therefore, we generated pDmrt1-Cre;Vegfa−/− (knockout,
KO) mice by crossing pDmrt1-Cre mice to floxed Vegfa mice to test whether loss of all VEGFA
isoforms in Sertoli and germ cells would impair spermatogenesis. When first mated, KO males
took 14 days longer to get control females pregnant (P < .02) and tended to take longer for all
subsequent parturition intervals (9 days; P < .07). Heterozygous males sired fewer pups per litter
(P < .03) and after the first litter took 10 days longer (P < .05) to impregnate females, suggesting

a more progressive loss of fertility. Reproductive organs were collected from 6-month-old male
mice. There were fewer sperm per tubule in the corpus epididymides (P < .001) and fewer
ZBTB16-stained undifferentiated spermatogonia (P < .003) in the testes of KO males. Testicular
mRNA abundance for Bcl2 (P < .02), Bcl2:Bax (P < .02), Neurog3 (P < .007), and Ret was
greater (P = .0005), tended to be greater for Sin3a and tended to be reduced for total Foxo1 (P <
.07) in KO males. Immunofluorescence for CD31 and VE-Cadherin showed no differences in
testis vasculature; however, CD31-positive staining was evident in undifferentiated
spermatogonia only in KO testes. Therefore, loss of VEGFA isoforms in Sertoli and germ cells
alters genes necessary for long-term maintenance of undifferentiated spermatogonia, ultimately
reducing sperm numbers and resulting in subfertility.
Male-related factors such as low sperm count and abnormal spermatogenesis are responsible for
50% of the infertility afflicting 2.1 million U.S. couples. The incidence of male infertility cases
has increased, resulting in the new disorder—testicular dysgenesis syndrome (1). Because
testicular dysgenesis syndrome can involve a range of little to aberrant spermatogenesis (2), a
misregulation of spermatogonial stem cell (SSC) homeostasis is a possible contributor. Little is
known about factors involved in development of SSCs; however, we do know SSCs differentiate
from primitive germ cells called gonocytes that must migrate from the center of the testicular
cords (tubules) to the periphery during testis development and that they also undergo
proliferation (self-renewal). This process occurs around postnatal days 3–5 in rodents after
mitotic arrest that begins around embryonic day (E) 17 (3–5). If no gonocyte migration occurs,
these cells undergo apoptosis and the population of SSCs does not form. Thus, factors that affect
SSC formation may also affect expansion of SSCs, whereas inhibition of these factors may cause
apoptosis and a reduced SSC pool. A balance between SSC self-renewal and differentiation is
needed to maintain spermatogenesis and male fertility.
Vascular endothelial growth factor A (VEGFA) is a paracrine growth factor responsible for
blood vessel development as well as endothelial cell migration. Although VEGFA isoforms are
primarily thought of as regulatory factors for blood vessel growth and maintenance, their
biological activities extend well beyond vascular biology. We have demonstrated that altering
VEGFA isoform activity in the testis in vivo results in significant changes in the ability of SSCs
to self-renew and colonize seminiferous tubules (6). Furthermore, expression of VEGFA in
normal testes, prostate, seminal vesicles, and semen suggests that VEGFA may be involved in
male fertility (7, 8).
The Vegfa gene is composed of eight exons that can be alternatively spliced to produce different
proangiogenic and antiangiogenic isoforms. In general, proangiogenic isoforms promote
development of vasculature, whereas antiangiogenic isoforms inhibit vascular development (9,
10). Studies have demonstrated VEGFA-positive staining surrounding specific germ cells and in
some germ-cell cytoplasm at E14, E16, E19, postnatal day (P) 5 and 5 (11). Expression of
VEGFA_164 was in germ cells from P3-P5 in mice at the time of gonocyte-to-SSC transition
and was reduced thereafter. In addition, antiangiogenic VEGFA isoforms were in some germ
cells at E14 and E16, the interstitium and faintly in Sertoli and germ cells at P0, and
undifferentiated spermatogonia after P5 and in primary spermatocytes and round spermatids at
P20 (6, 12). Recent data from our laboratory have demonstrated that VEGFA isoforms can affect
SSC renewal and proliferation depicted through SSC transplants into recipients. The

antiangiogenic isoform, VEGFA_165B, inhibited SSC colonization, suggesting that they inhibit
SSC self-renewal or stimulate SSC differentiation. Antibodies to the proangiogenic isoform,
VEGFA_164, also inhibited formation of colonies in recipients, indicating that VEGFA_164 is
necessary for SSC renewal (6). Taken together, these data suggest that a balance of VEGFA
isoforms is necessary to regulate the SSC pool and male reproductive lifespan.
For the current study, we proposed that VEGFA plays an important role in SSC renewal and
differentiation. To investigate the effects of VEGFA in vivo, we generated Sertoli-germ-cellspecific VEGFA isoform null (both proangiogenic and antiangiogenic) transgenic mice using a
pDmrt1-Cre. The objective of the present study was to determine the in vivo effects of Sertoligerm-cell-specific VEGFA loss on male reproductive phenotypes including genes involved in
the regulation of undifferentiated spermatogonia, spermatogenesis, and testis morphogenesis.

Materials and Methods
Animals
Sertoli and germ-cell VEGFA knockout (KO) mice were obtained using the Cre-lox approach
using a line of Vegfa floxed mice (13) mated with pig doublesex and mab-3-related transcription
factor 1 (Dmrt-1-1) promoter (pDmrt-1)-Cre mice (14). Homozygous Vegfa floxed mice were
mated to mice positive for the pDmrt-1-Cre allele. The resulting F1 heterozygous mice were first
mated back to the homozygous Vegfa floxed founders to generate the F2 population and then
were collected for the study (see Supplemental Figure 1, published on The Endocrine Society's
Journals Online web site at http://endo.endojournals.org). Control and homozygous KO mice
were from the F2 generation. We used Cre-negative Vegfa−/− or Vegfa+/− mice as controls and
Cre-positive Vegfa−/− mice as KOs (pDmrt1-Cre;Vegfa−/−) or Cre-positive Vegfa+/− as
heterozygotes (Het). Dmrt1 is expressed in the indifferent mouse gonad at E10.5 in precursor
cells that differentiate into Sertoli cells in males and granulosa cells in females. Murine Dmrt1 is
expressed in Sertoli cells and in germ cells within testes and in somatic and germ cells within
ovaries at E12.5. By E13.5, expression is no longer detectable in ovarian somatic cells.
Expression of Dmrt1 in the testis increases from E13.5 through E15.5. Germ cell expression of
Dmrt1 mRNA is detectable in premeiotic spermatogonia (15), and expression has been detected
in Sertoli cells of all stage tubules up to the first spermatogenic wave (16, 17). The pDmrt1 gene
is expressed similarly to mouse Dmrt1 (14). In our pDmrt1-Cre;Vegfa−/− mouse, Cre
recombinase activity is driven by the pDmrt1 promoter and excises exon 3 of the Vegfa gene.
Exon 3 is present in both proangiogenic and antiangiogenic isoforms; thus, all Vegfa isoforms
are affected in the cells where Dmrt1 is expressed. Body and organ weights were evaluated in 6month-old male mice (n = 9 controls, n = 8 KO), and at kill, testes, epididymides, prostates,
seminal vesicles, kidneys, and adrenals were collected for analysis.
All animal protocols were approved by the University of Nebraska Institute of Animal Care and
Use Committee in accordance with the National Institutes of Health Guide for the Care and Use
of Laboratory Animals. All animal models were procured from collaborating investigators with
verbal or written MTA agreements. Thus, the corresponding author does not have rights to freely
distribute these mouse lines.

Genotyping
Genomic DNA was extracted from tail samples by proteinase K digestion, followed by 6 M
NaCl extraction and ethanol precipitation for genotyping via conventional PCR. DNA was
amplified for 30 cycles after an annealing temperature of 54°C to detect floxed Vegfa.
Expression of pDmrt1-Cre was detected from DNA annealed at 55°C and amplified for 34 cycles
with a forward primer for pDmrt1 and a reverse for Cre.
After RNA was extracted from testes and converted to cDNA, RT-PCR was also used to
determine gonadal Cre expression in each of the collected organs. All males that did not have
Cre expressed within testes or that had Cre expressed in other organs were removed from
analysis. Sequences for the primers used in PCR can be found in Supplemental Table 1.

Hormone assays
Trunk blood was collected at the time of euthanasia and placed into tubes with 20 μL potassium
EDTA solution (0.01 M EDTA diluted 30% in PBT; Fisher Scientific). Blood samples were
immediately centrifuged at 1250g for 10 minutes. The separated plasma was then collected into a
new tube and stored at −80°C. Testosterone concentrations were determined by a testosterone
ELISA kit (catalog no. 1880; Alpha Diagnostics International Inc) (18). A standard curve was
established using 0 ng/mL, 0.5 ng/mL, 1 ng/mL, 2.5 ng/mL, 10 ng/mL, and 20 ng/mL samples.
Assay sensitivity was 0.125 ng/mL and intra-assay coefficient was 4.29%.

Fixation, embedding, staining, and immunohistochemistry
Representative tissues were fixed in Bouin's solution and paraffin embedded according to
standard procedures (19). Tissues were sectioned (5 μm), and immunohistochemistry (IHC) was
performed as previously described (19). The VEGFA antibody was a rabbit polyclonal IgG
raised against a peptide corresponding to amino acids 1–140 of human VEGFA (catalog no. sc507; Santa Cruz Biotechnology). It served as a pan-antibody for both proangiogenic and
antiangiogenic isoforms to determine if any VEGFA isoforms were present in Sertoli and germ
cells within KO and control mouse testes. The primary antibody was diluted 1:100 in 10%
normal goat serum (NGS). As a negative control, serial sections were processed without primary
antibody. Biotinylated goat antirabbit secondary antibodies were diluted 1:300 in 10% NGS and
used with each primary antibody in this study (catalog no. BA-1000; Vector Laboratories). The
secondary antibody was detected using aminoethyl carbazole chromagen substrate solution
(Invitrogen). Similar immunohistochemistry protocols were used for additional primary
antibodies. The zinc finger and BTB domain containing 16 (ZBTB16, also known as PLZF)
primary antibody (catalog no. sc-22839; Santa Cruz Biotechnology) was diluted 1:500 in 10%
NGS. Phosphorylated Forkhead box O1 (FOXO1; Ser 256) was diluted 1:300 in 10% NGS
(catalog no. ab131339; Abcam).

Fertility trials
Male and female mice were paired when they were approximately 2–4 months of age and
continued until they were 6 to 8 months of age. Control, Het, and KO male mice were all paired

with control female mice of proven fertility. The time from when males and females were placed
together in cages to the time of parturition was measured in days. We also determined the
number of pups per litter. We began the fertility study with 12 pairs each control × control, Het ×
control, and KO × control. However, after the fertility study, PCR analysis of Cre in the testis
was conducted and, if Cre was expressed in other organs as well, animals were removed from the
analysis. This inappropriate Cre expression led to reduced numbers of Het × control and KO ×
control pairs for analysis.

Immunofluorescence
Testes were processed for immunofluorescence similarly to the previously mentioned IHC with
the exception of using PBS with 0.05% Tween 20 (catalog no. BP337–100; Fisher Scientific)
added. Two primary antibodies were used: rabbit antibody to CD31 (PECAM; catalog no.
ab28364; Abcam) and a goat antibody to VE-CADHERIN (catalog no. sc-6458; Santa Cruz
Biotechnology). Both were diluted 1:50 in 3% BSA (catalog no. A3311; Sigma-Aldrich) in PBSTween. An antirabbit FITC secondary antibody (Alexa Fluor 488; catalog no. 4412S; Cell
Signaling Technology) was added to bind the CD31 primary antibody. To detect expression of
VE-CADHERIN, we used an antigoat Texas Red secondary antibody (Alexa Fluor 594; catalog
no. A-21223; Invitrogen/Life Technologies). Each of the secondary antibodies was diluted 1:400
in 3% BSA in PBS-Tween. Once each of the primary antibodies was optimized with their
corresponding secondary antibodies, testes were dual labeled with a mixture of both primary
antibodies followed by a mixture of both secondary antibodies. Staining was moved to a dark
room just before the fluorescent secondary antibodies were added. Following this incubation and
washing in PBS-Tween three times, slides were mounted with VECTASHIELD HardSet
Mounting Medium with 4′,6-diamidino-2-phenylindole (DAPI; catalog no. H-1500; Vector
Laboratories) and cover-slipped. Slides were imaged in a dark room using SlideBook 4.2
Software (Intelligent Imaging Innovations) and using an IX71 Olympus Inverted Brightfield and
Fluorescence Microscope (Hitschfel Instruments). In addition to sections with all antibodies
added, slides had two more isolated sections: one without any antibodies and one with only
secondary antibodies added. These negative controls confirmed how much fluorescence was
background. Two images were taken at ×100 and ×400 as well as three images at ×200 of both
control (n = 5) and KO (n = 4) testes.

Determination of undifferentiated spermatogonia and sperm numbers
Testis sections used for ZBTB16 immunohistochemistry were examined at ×200 magnification
with an Olympus BX51 Microscope (Olympus America), and images were captured using
cellSens digital imaging software (Olympus America). The number of undifferentiated
spermatogonia per tubule was identified as being positive for ZBTB16 staining in each
microscopic field and was determined from four randomly chosen, nonoverlapping fields from
the center section of each testis per animal. The number of positively stained spermatogonia was
averaged per testis, and this average was compared between KO (n = 7) and controls (n = 6).
Hematoxylin and eosin-stained epididymal sections were examined at ×400 using the same
camera and software. The number of spermatozoa within the corpus epididymis per tubule for
each microscopic field was determined from five randomly chosen fields per epididymis per
animal. The number of spermatozoa from these five microscopic fields was averaged per tubule,

and this average was compared between KO (n = 5) and control (n = 4) mice. For the same
animals and images, we measured tubule area in the corpus epididymides using ImageJ software
(National Institutes of Health).

Quantitative RT-PCR (qPCR)
One testis was collected from each animal for RNA extraction, RT to cDNA and qPCR analysis
according to previous protocols (19). RNA samples were stored at −80°C until RT was
performed using the SuperScript III reverse transcriptase (Invitrogen). Real-time PCR was
performed to determine residual genomic DNA. Samples were stored at −20°C until used for
qPCR. Equivalent amounts of cDNA were added to master mixes for qPCR. TaqMan Universal
PCR and Power SYBR Green Master Mixes were used (Applied Biosystems). Reactions used
150- or 300-nm primers depending on validation, and TaqMan reactions required 2-μM probe.
Primers were designed with Primer Express 3.0 software (Applied Biosystems) and synthesized
at Integrated DNA Technologies unless otherwise stated. Genes that required SYBR Green to
measure quantification were also plotted on a dissociation curve to ensure primer dimerization
was not detected. qPCR was conducted according to previous protocols (19). TaqMan Gene
Expression Assays were used to detect expression of four genes: glial cell line derived
neurotrophic factor (Gdnf), ret proto-oncogene (Ret), SIN3A (Sin3a), and neurogenin 3
(Neurog3) (catalog no. 4331182; Applied Biosystems). Probes were designed in our laboratory
and purchased for two genes: BCL2-associated X protein (Bax) and B-cell leukemia/lymphoma 2
(Bcl2) (Applied Biosystems). Primer and probe sequences for each gene are listed in
Supplemental Table 1. mRNA abundance was normalized to expression of the housekeeping
gene, glyceraldehyde-3-phosphate dehydrogenase (Gapdh), and represented as fold changes
relative to the mean control value (set at a value of 1). The expression of Gapdh was determined
using a VIC probe and primer kit (catalog no. 4308313; Taqman Rodent GapDH Control
Reagents; Applied Biosystems). Values were expressed as means ± SEM.

Terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) assay
Middle sections of control and KO testes were assayed for apoptosis according to a previously
devised protocol (catalog no. G3250; Promega). Slides were mounted using a VectaStain mount
with DAPI (Vector Laboratories). Testes were imaged in a dark room using SlideBook 4.2
Software (Intelligent Imaging Innovations) and using an IX71 Olympus Inverted Brightfield and
Fluorescence Microscope (Hitschfel Instruments). TUNEL-positive cells fluoresced bright green
(FITC filter, 488 nm), whereas nuclei shone bright blue because of the DAPI (360–460 nm).
Because of no observable differences in apoptosis between KO and control at ×100
magnification, we did not conduct further analysis.

Statistical analysis
Data were analyzed using a one-way ANOVA with a Dunnett's test to compare KO to controls
(JMP software; SAS Institute). Differences in data were considered statistically significant when
P < .05. Fertility data were analyzed with JMP software (SAS Institute) with one-way ANOVA,
and the treatment means were compared with a Student t test. Differences were considered

significant at P < .05. Trends toward significance were considered if .05 > P < .1. All treatments
were compared relative to controls.

Results
Validity of pDmrt1-Cre;Vegfa−/− KO phenotype
Immunohistochemistry with a pan-VEGFA antibody that detects both angiogenic and
antiangiogenic isoforms was used to determine how deletion of Vegfa isoforms in Sertoli and
germ cells affected protein expression of VEGFA isoforms in those cell types. There was a
reduction of VEGFA isoforms in Het (Figure 1B) and KO testes (Figure 1C) vs controls (Figure
1A), especially in Sertoli cells within the seminiferous tubules. To determine global reductions in
of VEGFA expression in seminiferous tubules, we used a chromaffin assay in our IHC to detect
protein expression of all VEGFA isoforms, both pro- and antiangiogenic. The KO mouse testes
had reduced expression of VEGFA isoforms in Sertoli cells and, thus, provide a valid model for
examining reduced VEGFA expression in the testis. Sections processed without primary
antibody lacked positive staining and served as negative controls (Figure 1D).

Fertility of pDmrt1-Cre;Vegfa−/− and heterozygote male mice
Mice were either mated: 1) male control to female control (Control × Control; n = 12); 2) male
KO to female control (KO × Control; n = 4); or 3) male Het to female control (Het × Control; n =
5). The number of days from the initial pairing of males with females to their first parturition was
14 days longer when male KO × control female matings (38.0 ± 11.8 d; P < .01) were compared
with control matings (24.1 ± 1.4 d; Figure 1E). Furthermore, when all parturition intervals were
analyzed, the KO male × control female matings tended to take 9 days longer to get females
pregnant when compared with control matings (33.5 ± 4.07 vs 24.5 ± 2.49 days; P < .07; Figure
1F). However, there were no differences in Het × Control matings at the first parturition. When
we continued to evaluate the Het × Control matings, interestingly, the time from the first to the
second parturition in the control females mated with the Het males was 10 days longer than
control matings (36.3 ± 2.7 vs 25.8 ± 3.4 d; P < .05). Surprisingly, we also observed a difference
in the number of pups per litter in the Het × Control matings with a two-pup reduction compared
with control matings (6.50 ± 0.65 vs 8.67 ± 0.75; P < .03; Figure 1G). However, there were no
differences in number of pups between KO × Control and Control × Control matings.

Vasculature in the testicular interstitium appeared unaltered in KO males, but
increased mitotic germ cells were different
The presence of undifferentiated spermatogonia has been demonstrated to be increased in
portions of seminiferous tubules that border interstitium and especially near vasculature (20). As
a result, we performed immunofluorescence to dual label for two known endothelial cell
markers—platelet cell adhesion molecule (PECAM-1 or CD31) and vascular endothelialcadherin (VE-CAD). Although our findings showed no apparent differences in testicular
vasculature in KO mice (Figure 2, J–L) compared with the testes of controls (Figure 2, G–I),
CD31-positive staining (green) was much more evident in germ cells in the testes of KO males

(Figure 2, D–F) that was not evident in any of the controls (Figure 2, A–C). Serial sections that
were processed without primary antibodies were used as negative controls (Figure 2, M–O).

Epididymal morphology was affected in pDmrt1-Cre;Vegfa−/− mice with reduced
corpus epididymal sperm numbers per tubule
There were alterations in morphology within the epididymis. The epididymis is important
because it is necessary for sperm cell maturation and capacitation. Morphologically, the
epididymides in KO mice appeared to have fewer tubules and less coiling than control
epididymides (Figure 3, A–F) with greater segmentation between different sections of the organ.
Epididymides of KO mice were 23% smaller than controls (0.030 ± 0.0026 vs 0.039 ± 0.0022 g,
P < .05; Figure 3G). In addition to the reduction in tubule numbers and epididymides weight, the
corpus epididymides in KO mice (28.07 ± 4.62; P < .002) also had 42% fewer sperm per tubule
compared with controls (48.45 ± 3.38; Figure 3H). Interestingly, the tubule area in the corpus
epididymides was significantly greater in the KO males (113 9491 ± 18 498 pixels; P < .03)
compared with controls (106 3001 ± 28 039 pixels; data not shown). In addition, although tubule
number did not differ between KO and control males, sperm numbers were still reduced in KO
males when not represented per tubule (189.8 ± 30.8; P = .0003) compared with control males
(357.2 ± 28.4; data not shown).

Alterations in testis morphogenesis in KO and Het mice compared with controls
Even though there was not a significant difference in testis weight, the seminiferous epithelium
of the testis was disorganized, with large vacuoles where germ cells normally reside in KO and
Het mice (Figure 4, A–F). In some cases, certain staged germ cells seemed to be located in
abnormal locations within tubules. We observed more of these morphologic alterations and
seminiferous disorganization within Het mice than KO mice testes.

Testicular expression of ZBTB16 protein
To determine the effect of VEGFA loss on populations of spermatogonia, we performed
immunohistochemistry for the undifferentiated spermatogonia marker ZBTB16 (also known as
PLZF). ZBTB16 is thought to be important for the self-renewal of undifferentiated
spermatogonia (21). The number of ZBTB16-positive undifferentiated spermatogonia per tubule
was decreased in KO testes (4.38 ± 0.29; P < .003; Figure 5B) compared with controls (6.60 ±
0.67; Figure 5A), demonstrating a loss of undifferentiated spermatogonia in KO mice at 6
months of age. Serial sections that were processed without primary antibody served as negative
controls (not shown).

Genes critical for SSC niche establishment and maintenance were altered in KO
mice testes with reductions in undifferentiated spermatogonia
Within the developing population of undifferentiated spermatogonia, there are several genes that
are important in undifferentiated spermatogonia (and possibly SSC) maintenance. One of those
factors, RET, is the receptor for the growth factor GDNF that, in the testis, is secreted by Sertoli
cells. GDNF-mediated RET signaling is important for the development of undifferentiated

spermatogonia (22, 23). The relative amount of Ret mRNA in testes from KO mice was greater
(3.53 ± 0.81; P = .0005) than that of controls (1 ± 0.16; Figure 6B). However, relative amounts
of Gdnf mRNA in KO testes were not different from controls (Figure 6A). NEUROG3 is a
transcription factor that is expressed in undifferentiated spermatogonia and those that
differentiate and ultimately give rise to spermatogenesis (24). The relative amount of Neurog3
mRNA in KO testes was significantly higher (1.67 ± 0.17; P < .007) than control testes (1 ±
0.14; Figure 6D). There was no significant difference in the amount of Zbtb16 mRNA between
KO and control testes (Figure 6C).
SIN3A, as a Sertoli cell product, affects spermatid elongation and is required by Sertoli cells to
establish a niche for undifferentiated spermatogonia because it appears to aid in spermatogonial
migration to the basement membrane (22). Relative amounts of Sin3a mRNA in KO testes
tended to be higher (1.82 ± 0.53; P < .08) than in controls (1 ± 0.15; Figure 6F). Kit ligand
(KITL) has been reported to be required for the survival and proliferation of germ cells and
spermatogonia in the testes (25). However, there was no difference between KO and control
testes for Kitl mRNA abundance (Figure 6E).

Genes critical for regulating cell apoptosis were altered in KO mice testes
Because VEGFA proangiogenic isoform treatment has been demonstrated to increase the
expression of BCL2 relative to BAX in bovine testis (26), we evaluated Bcl2 and Bax mRNA
expression in the conditional KO vs control testis. Levels for Bcl2 mRNA in KO testes were
higher (2.38 ± 0.66; P < .02) than those in control testes (1 ± 0.14; Figure 7A). However, there
was no difference in mRNA abundance for Bax in KO testes compared with controls (Figure
7B). Furthermore, the ratio of Bcl2 to Bax mRNA levels in mice with Sertoli-germ-cell-specific
VEGFA loss was increased (2.24 ± 0.61; P < .02) compared with controls (1 ± 0.16; Figure 7C).
In addition, mRNA for Caspase 3 (Casp3), a factor that promotes cell apoptosis, was not
different between KO and control testes (Figure 7D).

Phosphorylated FOXO1 immunohistochemistry is more cytoplasmic in KO
mouse testes
FOXO1 is a transcription factor that has been suggested to be important for either self-renewal or
differentiation of undifferentiated spermatogonia depending on whether it is phosphorylated
(27). Phosphorylated FOXO1-positive staining appeared less intense and more cytoplasmic in
KO testes (Figure 8B) when compared with controls (Figure 8A). Sections processed without
primary antibody lacked positive staining and served as negative controls (Figure 8C). In
addition, the mRNA abundance of total Foxo1 tended to be reduced (57%) in the testes of KO
mice (0.43 ± 0.16; P < .07) compared with control mice (1 ± 0.18; Figure 8D).

Body weight was reduced in KO mice
In KO mice, body weight (28.52 ± 0.48 vs 32.52 ± 1.20 g, P < .02; Supplemental Figure 2F) was
reduced 12.3% compared with those from control mice. In addition, the prostate tended to be
55% smaller (0.01 ± 0.0031 g vs 0.022 ± 0.0045 g; P < .07; Supplemental Figure 2B). Although
reductions in body weight were observed in comparison to controls, no differences in testis,

seminal vesicles, kidneys, and adrenal gland weights were detected (Supplemental Figure 2, A
and C–F). Plasma testosterone concentrations were also not different compared with control
mice (Supplemental Figure 2G) at 6 months of age when the mice were collected.

Discussion
In the present study, we present novel data that VEGFA isoforms secreted by Sertoli cells and
germ cells are necessary for maintenance of undifferentiated spermatogonia, sperm numbers, and
normal male fertility. Again, the pDmrt-1-Cre transgene was detected in mouse Sertoli cells and
in some germ cells; however, endogenous mouse DMRT-1 does not appear to be translated in
germ cells (17). Elimination of all VEGFA isoforms resulted in subfertility, with longer intervals
to get females pregnant or achieve viable offspring, and this occurred even when one allele was
conditionally knocked out. Furthermore, these data support a recent publication by our laboratory
and collaborators that treatment with either proangiogenic or antiangiogenic VEGFA isoforms
affect genes regulating the SSC niche, presumably by altering the ability for them to renew or
differentiate (6).
In KO testes, the expression of genes that are thought to regulate either renewal or differentiation
of undifferentiated spermatogonia was altered. Genes expressed in undifferentiated
spermatogonia (Ret), in both undifferentiated and early differentiated (Neurog3) and in Sertoli
cells (Sin3a), had greater mRNA abundance (or tended to) compared with controls. NEUROG3
is expressed in most if not all undifferentiated spermatogonia and all those that will give rise to
spermatogenesis (24). Loss of both RET and SIN3A causes SSC depletion in mice (22, 23), and
inhibition of GDNF signal transduction through RET dramatically impairs SSC renewal (28).
In addition, total Foxo1 mRNA tended to be reduced in the testes of KO males, and
phosphorylated FOXO1 appears to be more cytoplasmic and less intensely expressed. FOXO1
belongs to a family of transcription factors known for their role in regulating cellular processes
including cell fate decisions (29, 30). Phosphorylation of FOXO1 results in translocation from
the nucleus to the cytoplasm (31). A study involving mice where Foxo1 was conditionally
knocked out in germ cells suggested a novel role for FOXO1 in SSC homeostasis (27). Its
nuclear translocation coincided with the initiation of differentiation (expression of c-kit), whereas
cytoplasmic, phosphorylated expression was associated with self-renewal. It was determined that
FOXO1 may regulate SSC renewal through its positive relationship with RET (27). Also,
VEGFA_164 has been demonstrated to up-regulate expression of GDNF and to phosphorylate
RET in the mouse kidney (32).
Although SIN3A is expressed by Sertoli cells and has been determined to be important for the
establishment of the SSC niche (22), it has also been shown to cause sterility when knocked out
in germ cells (33). SIN3A functions as a transcriptional corepressor, and one of its targets is
ZBTB16 (34). Although mRNA abundance for Sin3a was increased in KO male testes in this
study, positive staining for ZBTB16 was reduced. In addition, SIN3A appears to be important for
indirectly regulating differentiation of germ cells. When the Zbtb16 gene is knocked out in germ
cells, the cells undergo apoptosis as they resume quiescence perinatally (33). The reduction in
ZBTB16-positive spermatogonia suggests that loss of VEGFA isoforms may deplete the SSC
pool. This supports previous research where injections of perinatal mice (P3–5) with either an

antibody to the proangiogenic isoform, VEGFA_164, or treatment with the antiangiogenic
isoform, VEGFA_165B, followed by spermatogonial transplantation at P8 and P21 decreased
SSC colonization in testes compared with controls. Combined with the data from this study, it
appears that the VEGFA_164 proangiogenic isoform may be critical for sustained SSC renewal,
proliferation, or survival that is necessary to maintain the SSC niche, whereas the antiangiogenic
isoform, VEGFA_165B, may promote differentiation of germ cells or their demise through
apoptosis (6).
Within the testes of KO mice, there were also differences in expression of genes that promote
survival: increased Bcl2 and Bcl2:Bax mRNA abundance. In other studies, recombinant mouse
VEGFA_164 treatment increased numbers of germ cells in cultured bovine testis explants
compared with controls. Furthermore, blocking VEGFA activity in vitro reduces the number of
germ cells in VEGFA-treated testis tissue (26). This suggests that proangiogenic VEGFA
isoforms are survival factors for germ cells and compensatory mechanisms may exist to enhance
prosurvival genes such as Bcl2.
With the absence of VEGFA isoforms, it seems the testis was attempting to increase the
transcription of factors to maintain the SSC niche (Sin3a), possibly renewal through enhanced
GDNF signal transduction (Ret) and cell survival (Bcl2 and Bcl2:Bax). Because NEUROG3 is
expressed in at least a majority of undifferentiated spermatogonia, its increased mRNA
abundance could also be indicative of an attempt to maintain the niche. The mRNA abundance
for total Foxo1 tended to be reduced and the positive staining for the phosphorylated FOXO1
appeared less intense in testes of KO males; however, the staining also appeared more
cytoplasmic. This is also suggestive of an attempt at compensating for VEGFA isoform loss. In
addition, Casp3 mRNA abundance was not different, and TUNEL staining was not different
between KO and control testes (data not shown), further suggestive of protective mechanisms to
maintain germ-cell survival. Because previous data suggest that antiangiogenic VEGFA isoforms
promote differentiation (6), their absence was presumably driving compensatory mechanisms as
well (increased Neurog3). The increase in survival factors may have been to maintain germ cells
at multiple stages seeing that there were both mature spermatozoa present in the epididymis as
well as undifferentiated spermatogonia in the testes. Compensatory mechanisms were able to
maintain fertility in the short term, but loss of VEGFA isoforms appears to cause a gradual
reduction in fertility as parity increases as demonstrated by the heterozygous males.
In addition to alterations in factors that regulate undifferentiated spermatogonia and survival,
body weight was reduced by 12%. The reason for the decrease in body weight in the current
study is unknown; however, it is possible that alteration of factors within the testis may have
affected body growth and also may have contributed to differences in morphology and size of the
prostate. Furthermore, factors produced by the testis have been demonstrated not only to increase
body weight and growth but also to affect morphogenesis of the epididymis and potentially
maintenance of its function (35).
Although testis weight was not different, vacuoles were visible where germ cells should reside in
Het and KO testes compared with controls. Previously, constitutive expression of VEGFA_121
under the control of the mucin 1 (Muc1) promoter resulted in subfertility in mice. Seminiferous
tubules were disorganized, and spermatogenesis appeared arrested in some of these mice (7). In

another study, overexpression of human VEGFA_165 in the testis and epididymis under the
control of the mouse mammary tumor virus promoter resulted in infertility through
spermatogenic arrest and endothelial cell hyperplasia (36).
Both Sertoli and germ cells secrete VEGFA, and it is involved in the production of plasmin
(urokinase plasminogen activator or uPA and tissue plasminogen activator or tPA) and plasmin
inhibitors (plasminogen activator inhibitor-1 or PAI-1), which may alter cell adhesion and the
ability for germ cells to migrate from the adluminal to luminal compartment through the bloodtestis barrier (37–40). Loss of VEGFA isoforms may result in reduced regulation of movement
as well as in the epithelial disorganization similar to what was seen when VEGFA_121 was
under control of either the Muc1 or mouse mammary tumor virus promoters (7, 36).
Furthermore, the loss of undifferentiated spermatogonia could be impairing communication
between Sertoli and germ cells, complicating the already disconnected communication between
Sertoli and germ cells.
In an attempt to elucidate whether the effects of VEGFA elimination in this study were due to
vascular alterations to the niche and subsequently the previously mentioned weakening of
Sertoli-germ-cell adhesion, we examined the expression of CD31 (PECAM-1) and VE-CAD.
Testicular vasculature was dual-labeled fluorescently for both proteins and was not dramatically
different between any KO and control testes. Although both endothelial cell markers appeared to
favor the interstitial compartment and vasculature, CD31-positive staining was seen in germ cells
in the KO testes stained and not in the controls. CD31 has been demonstrated to be an important
receptor on human sperm to potentially initiate capacitation (41, 42). Also, CD31 has also been
shown to label migrating male-specific endothelial cells (43). Finally, although CD31 has been
demonstrated to be important for adherence, CD31-positive staining in migratory germ cells
suggests that it is required for adherence to Sertoli cells in the testis (42). Expression of VE-CAD
did not appear different between KO and control testes; however, it could be seen in the
interstitium as well as in what appear to be adherens junctions between Sertoli cells and possibly
some germ cells.
Removal of VEGFA isoforms in Sertoli and in subpopulations of germ cells resulted in smaller
body, epididymal, and prostate weights, altered expression of testicular genes regulating cell
apoptosis, and undifferentiated spermatogonia, and in increased expression of CD31 in germ
cells. Furthermore, KO mice had reduced numbers of undifferentiated spermatogonia in the testis
and numbers of sperm in the corpus epididymis, which would result in reduced male fertility.
Therefore, whether the effects are direct or indirect, the collective results in this study
demonstrate that VEGFA is a regulator of genes that are necessary for maintenance of
undifferentiated spermatogonia, sperm production, and male fertility.
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Footnotes
Abbreviations:
DAPI

4′,6-diamidino-2-phenylindole

E
embryonic day
FOXO1
Forkhead box O1
GDNF
glial-cell line-derived neurotrophic factor
Het
heterozygotes
IHC
immunohistochemistry
KO
knockout
NGS
normal goat serum
P
postnatal day
qPCR
quantitative RT-PCR
SSC
spermatogonial stem cell
TUNEL
terminal deoxynucleotidyl transferase dUTP nick end-labeling
VE-CAD
vascular endothelial-cadherin
VEGFA
vascular endothelial growth factor A.
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Figures and Tables
Figure 1.

Immunohistochemistry with panVEGFA antibody at ×400 magnification in a control testis (A),
heterozygous (Het) testis (B), and a KO testis (C). Negative control testes were processed
without primary antibody (D). Results from the fertility trial with males as the first present in
each pair (Control, Het, KO) were broken into days from mating to first parturition (E), the
average number of days between each parturition interval (F), and average number of pups born
per litter (G). For the Control × Control, Het × Control, and KO × Control pairs in (E), n = 12, 5,
and 4, respectively. For the Control × Control, Het × Control, and KO × Control pairs in (F) and
(G), n = 16, 8 and 6, respectively. Results represented by different letters were significant when
P < .05; †, data tended to be significant (.05 < P < .1).

Figure 2.

Fluorescent images of mouse testes at ×200 focusing on both tubules and blood vessels in control
mice (A–F) and knockout mice (G–L). CD31-positive staining is green (A, D, G, J). VE-CADpositive staining is red (B, E, H, K). Merging of the two appears yellow where coexpressed (C,
F, I, L). Negative controls were processed without primary antibodies. Pictured are negative
control images viewed with the FITC filter (M), the Texas Red filter (N), and finally the merge
with background reduced (O).

Figure 3.

Hematoxylin-eosin staining in the epididymides of controls (A, C) and KOs (B, D) at ×40 and
×100. Inset views of control (E) and KO (F) epididymides are at ×400. The number of
spermatozoa per tubule in the corpus epididymis from control (n = 20) and KO males (n = 23) is
represented (G). *, Results were significant when P < .05.

Figure 4.

Hematoxylin-eosin staining of testis cross-sections in black and white of ×200 control (A), ×400
control (B), ×200 heterozygote (Het) (C), ×400 Het (D), ×200 KO (E), ×400 KO (F). Arrows
denote seminiferous epithelium disruptions.

Figure 5.

ZBTB16-positive staining at ×200 magnification in cross-sections of control (A and C) and KO
(B and D) testes. Undifferentiated spermatogonia that stained positive for ZBTB16 are denoted
by red-brown staining. Also represented are the counts of ZBTB16-positive undifferentiated
spermatogonia represented per tubule between control (n = 24) and KO (n = 27) testes (E). *,
Results were significant when P < .05.

Figure 6.

Whole testis mRNA abundance of genes that regulate undifferentiated spermatogonia: Gdnf (A),
Ret (B), Zbtb16 (C), Neurog3 (D), Kitl (E), and Sin3a (F). Mean KO values (n = 8–17) are
represented as fold changes ± SEM compared with control (n = 5–9) mean (set to 1). *, Results
were significant when P < .05; †, data tended to be significant (.05 < P < .1).

Figure 7.

Whole testis mRNA abundance of genes that regulate apoptosis and survival: Bcl2 (A), Bax (B),
Bcl2:Bax (C), and Casp3 (D). Mean KO values (n = 11–17) are represented as fold changes ±
SEM compared with control (n = 5–9) mean (set to 1). *, Results were significant when P < .05.

Figure 8.

Immunohistochemistry depicted at ×400 for phosphorylated FOXO1 in the testes of control
males (A) and KO males (B). A negative control testis was processed without primary antibody
(C). Arrows point to cytoplasmic phosphorylated FOXO1 staining in the KO testis (B). Total
Foxo1 mRNA abundance in the testis was measured and compared between control (n = 11) and
KO (n = 5) males (D). †, Results were significant when 0.05 < P < .1.
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